ALZN (alzamend.com) Bozor qiymatining balans qiymatiga nisbati
Alzamend Neuro, Inc. (ALZN) Altsgeymer kasalligini to'xtatish uchun litiyni miyaga xavfsiz yetkazib berishning LiPRO metodini joriy qilmoqda. GURU.Markets terminalining ushbu grafigi narxning buxgalteriya qiymatiga nisbati tendentsiyasini aks ettiradi, bunda joriy ko'rsatkich 0.94 ni tashkil etadi. Ishlab chiqarishni autsorsing qilish modeli xarajatlarni minimallashtiradi, kuchli xususiy qo'llab-quvvatlash esa ekspertlarning ehtiyotkorona kutganlari bilan birga namoyon bo'lmoqda.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ALZN_-_Alzamend-Neuro-Inc._-_Capitalization-to-Book-Value-Ratio "ALZN Alzamend Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Alzamend Neuro, Inc. (ALZN) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Alzamend Neuro, Inc.|ALZN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati alzamend.com|ALZN - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Alzamend|ALZN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Alzamend Neuro
Kompaniyaning dastlabki tahlili:Alzamend Neuro Inc. - ALZN
Ushbu koeffitsient Alzamend Neuro, Inc. (ALZN) bozor qiymatini uning sof aktivlariga solishtirib, aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlaydi. Klinik sinovlar xarajatlari daromadlardan tezroq o'sayotgan kompaniya uchun ushbu metrika kelajakdagi kashfiyotlarga nisbatan bozor optimizmini aks ettiradi. Alzamend Neuro, Inc. (ALZN) ning joriy P/B koeffitsiyenti 0.94 ni tashkil etib, investorlarning real vaqtdagi konsensusini ifodalaydi. Ushbu ko'rsatkichning tendentsiyasi biznesning sovishining yashirin bosqichlarini ochib beradi. Yuqori qiymat kapital uchun haddan tashqari ko'p to'lash xavfi haqida signal beradi.
Toʻgʻridan-toʻgʻri raqobatchilar
Bozor qiymatining balans qiymatiga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TRVI|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. (PRAX)|Bozor qiymatining balans qiymatiga nisbati Anavex AVXL|CeriBell Corp (CBLL) - Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Prothena PRTA|Alector Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX: Bozor kapitallashuvining balans qiymatiga nisbati|OMER (omeros.com) - Bozor qiymatining balans qiymatiga nisbati|Neurogene Inc (NGNE) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ACIU (AC Immune Corp)|Bozor qiymatining balans qiymatiga koeffitsiyenti VYGR|Bozor qiymatining balans qiymatiga nisbati Neumora Therapeutics NMRA|Kapitallashuvning balans qiymatiga nisbati scilexholding.com (SCLX)|TVGN - Bozor kapitallashuvining balans qiymatiga nisbati|ACOG - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Cognition Therapeutics, Inc. (CGTX)|IKT: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Cassava Sciences, Inc.|Assertio (ASRT) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati COYA (Coya Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti VistaGen Therapeutics Inc (VTGN)|Kapitallashuvning sof aktivlarga nisbati OVID|Bozor kapitallashuvining balans qiymatiga nisbati ABOS (Acumen Pharmaceuticals, Inc)|Bozor qiymatining balans qiymatiga nisbati CervoMed Inc.|Alterity Therapeutics Ltd. - Balans qiymatiga nisbatan bozor qiymati|CLNN (Clene Nanomedicine) - Bozor qiymatining balans qiymatiga nisbati|PepGen Inc. (PEPG) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Jupiter Neurosciences JUNS|Relmada Corp (RLMD) - Balans qiymatiga nisbatan bozor qiymati|ANVS: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi GRCE|Bozor qiymatining balans qiymatiga nisbati Firefly Neuroscience AIFF|Kapitallashuvning balans qiymatiga nisbati anewmeds.com (KLTO)|NeuroSense Therapeutics Ltd. - Bozor kapitallashuvining balans qiymatiga nisbati|RVPH - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati MTVA (MetaVia, Inc.)|NRXS - Balans qiymatiga nisbatan bozor kapitallashuvi|HSDT: Bozor kapitallashuvining balans qiymatiga nisbati|PASG (Passage Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Neuphoria Therapeutics, Inc.|Bozor qiymatining balans qiymatiga nisbati Minerva (NERV)|ATHA - Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ADXN (addextherapeutics.com)|CYCN - Bozor qiymatining balans qiymatiga nisbati|Protagenic Therapeutics Inc. - Kapitallashuvning balans qiymatiga nisbati|Pasithea (KTTA) - Bozor qiymatining balans qiymatiga nisbati|CRGT - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXI|Bozor qiymatining balans qiymatiga koeffitsiyenti brainstorm-cell.com|CARA (Cara Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CHRO|Eliem Therapeutics (ELYM) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ITCI (intracellulartherapies.com)|LBPH: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti marinuspharma.com MRNS|NKGen Biotech - Bozor kapitallashuvining balans qiymatiga nisbati|NRBO: Bozor kapitallashuvining balans qiymatiga nisbati|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Synaptogenix, Inc|Kapitallashuvning sof aktivlarga nisbati Trevena, Inc. TRVN|Sof aktivlarga nisbatan bozor kapitallashuvi Vigil Neuro|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Bozor kapitallashuvining balans qiymatiga nisbati CERE (Cerevel Therapeutics Inc)